Weight Loss And ...

What if the medications that were supposed to fix obesity turned out to be just the beginning of the story? After decades of studying weight loss, Holly and Jim thought they had seen it all. Then a new class of medications arrived and overturned some of their most basic assumptions.

In this episode, each of them brings five things that genuinely surprised them about the GLP-1 era. Some are about the science, some are about what they see in patients, and some are about what these medications were expected to solve but haven't. Two longtime experts admit what they got wrong, what they're still puzzling over, and where they disagree. Join Holly and Jim for a candid look at where obesity treatment stands now, and why they believe the most interesting questions are only just being asked.

Discussed on the episode:

• The question Holly and Jim never imagined asking in their careers, and why the answer may change what "success" means
• Why a tool once thought impossible outside the operating room is now in the hands of many
• The appetite finding that went against everything they'd taught about the body's backup systems
• What the medications haven't changed (so far), and why that disappointed one of them more than it surprised them
• A hormone-based therapy with a risk profile that Holly says doesn't behave the way hormones usually do
• The hidden "background noise" that patients only noticed once it was gone, and the swing Holly predicts is coming next
• Why so many people walk away from a treatment that works, and the two-track approach Jim and Holly take to that
• One medication, a surprisingly long list of possible uses, and a few that may raise your eyebrows
• Why Jim believes weight loss and successful obesity treatment may not be the same thing
• Their predictions for what will surprise us five and ten years from now

You’ve hit your goal weight, or you’re close. So why doesn’t life feel as different as you expected? For many people, the number on the scale was never really the point. It was a stand-in for feeling confident, joining in, and finally enjoying life.

Today’s weight loss medications are helping people lose weight that once felt out of reach. A large new BMJ analysis asked whether quality of life is keeping pace, and the answer may make you rethink what success means. Join Holly and Jim as they dig into the findings, why feeling better and weighing less don’t always move together, and share what they’d do about it.

You’ll leave with practical, doable steps you can start now, long before you reach your goal weight. Press play to find out what to work on alongside your weight loss.

Discussed on the episode:

• What a huge new review of nearly 100,000 participants revealed about weight loss and quality of life
• The surprising gap between how much weight people lose and how much better life gets
• Why “quality of life” and “happiness” aren’t quite the same thing, and why the difference matters
• The question Holly asks every patient that gets underneath the number they say they want
• Why waiting to be happy until you reach your goal could work against you.
• A simple fill-in-the-blank exercise to uncover what you really want your weight loss to make possible
• The “life score” you may want to track alongside your weight
• Feeling better but being disappointed is completely normal, and what to do if the medication itself is part of the problem.
• A rapid-fire round that puts the hosts on the spot, including a food noise question Holly says isn’t fair.
• The pattern Holly admits she’s guilty of, and what it means for celebrating your wins

Resources mentioned:

• Nong et al., "Comparative Effects of Drugs for Adults with Overweight or Obesity: A Systematic Review and Network Meta-Analysis," BMJ (2026).
• *Losing the Weight Loss Meds* book by James Hill and Holly Wyatt
• Weight Loss And… Episode 147: The Weight Comes Off Easy. Now What?
• Weight Loss And… Episode 146: Losing Weight on GLP-1s: Are You Moving More or Less Than Before?
• Weight Loss And… Episode 145: Are You Eating Healthier While Eating Less on GLP-1 Medications?

Your friend just started semaglutide. She got it online; it's "compounded," it has B12 in it, and it's only $199 a month. Sounds like a great deal, right? But what exactly is in that vial, who made it, and how much are you supposed to take? More and more people are facing these questions every day, and most of us don't know how to answer them.

Join Holly and Jim as they welcome not one, not two, but three guests for the very first time: Misty Gaddis, pharmacy manager of medication compounding safety; Jessica Pescatore, clinical director of the Alabama Poison Information Center; and Richelle Chambliss, a clinical pharmacist who supports UAB's weight management clinics. Together, they pull back the curtain on compounded GLP-1s and share what your pharmacist wants you to know about weight loss medications, from dosing and side effects to insurance, access, and stopping and restarting. You'll come away with practical questions to ask and red flags to watch for before you inject anything.

Discussed on the episode:

• Why "compounded" doesn't mean "generic," and the common misconception that could put you at risk
• The real reason B12 shows up in so many online semaglutide products (and whether it's doing anything for your weight loss)
• What the Poison Center hears when dosing goes wrong, and why compounded products create a whole new level of risk
• The surprising truth about why the cheapest option may not be the cheapest for long
• A tempting shortcut to save money that pharmacists urge you not to take
• Why the "best" dose may not be the highest one
• What can happen when you stop and restart your medication on your own
• The red flags that should make you pause before taking anything you've ordered online
• The underrated ways your pharmacist can help you succeed, and when to call them
• A question Holly and Jim have never asked in decades of weight loss work, and why it's now on the table

New obesity medications can now produce weight loss once thought impossible without surgery. That success is forcing doctors to ask a question they never had to face before: what if a treatment doesn't know when to stop?

Join Holly and Jim as they unpack six new questions these next-generation drugs have raised in obesity medicine. Using a relatable patient case, they explore the difference between losing the maximum amount of weight and losing the optimal amount, and why those two things are no longer the same. You'll also hear where lifestyle fits into treatment now, what "success" really means when the scale isn't the whole story, and why the answers may ultimately come down to a conversation between patient and provider.

Discussed on the episode:

• Why hitting the weight-loss "ceiling" used to save doctors from a decision they never had to make
• A patient case that reveals what happens when someone loses more weight than she may actually need
• The hidden trade-off between the number on the scale and what's happening to muscle and strength
• Why nutrition and physical activity haven't become less important on these medications, just different
• The rapid-fire round that puts Holly and Jim on the spot with some of obesity medicine's toughest new dilemmas

If losing weight made movement easier, wouldn’t you naturally start moving more? It’s the kind of assumption that feels almost too obvious to question: shed 40 or 50 pounds, and your knees stop aching, the stairs get easier, and you’re out there living more. Holly and Jim certainly believed it. But in the age of GLP-1 medications, where rapid, substantial weight loss is now common, does this assumption still hold up?

In this episode, Holly and Jim put that belief to the test with real data. Diving into three separate studies (including brand-new, cutting-edge research), they explore what happens to physical activity levels once people start losing weight on GLP-1s. The results might surprise you, and as Jim warns early on, they might leave you feeling a little deflated too. But stick around, because Holly and Jim don’t just deliver the bad news; they explain why it matters and what you can actually do about it.

Discussed on the episode

• The surprising step-count numbers researchers found when they measured GLP-1 users with wearable devices and why the results left Jim unimpressed.
• What happened when scientists tracked the same people’s activity levels before and after starting a GLP-1 medication (hint: it wasn’t what anyone expected)
• Why a control group matters so much in this kind of research, and what’s still missing from the picture
• The difference between “free living” activity and structured exercise, and which one may be quietly declining
• A few theories on why physical activity might dip on these medications, and why even Jim isn’t fully convinced by any of them
• Five practical strategies for making sure your activity level doesn’t get left behind while the pounds come off
• Holly and Jim’s honest, personal reactions to research that challenges something they’ve believed for years

Everyone knows GLP-1 medications help people eat less. But does eating less actually mean eating better? It’s a question the weight loss field never really had to ask before, and the answer might surprise you.

Join Holly and Jim as they dig into three GLP-1 studies looking at what people are actually eating. You’ll hear the real numbers behind diet quality, protein intake, and nutrient gaps on these medications, plus what it means for anyone currently taking (or considering) a GLP-1. Holly and Jim also share five practical tips to help ensure your diet works as hard as your medication is.

Discussed on the episode

• Why losing weight on a GLP-1 doesn’t automatically mean you’re eating a healthier diet
• The surprising “Healthy Eating Index” scores researchers found in people taking these medications.
• Which micronutrients tend to slip through the cracks when food intake drops
• The protein timing pattern showing up in the data and why it might matter.
• Whether cravings actually go away on GLP-1s, or if that’s a myth
• Five things anyone on a GLP-1 can do right now to protect their diet quality
• Answers to listener questions on appetite loss, ongoing hunger, and whether there’s a “best” GLP-1 diet
• A teaser for the next episode, which flips the lens to physical activity on GLP-1s

Think you know what it takes to keep weight off? Most people can tell you how to lose weight, but ask them what actually predicts keeping it off, and the answers get shaky fast. That’s a problem, because losing weight and maintaining weight loss are two completely different biological and behavioral games, and confusing the two is one of the biggest reasons people yo-yo.

In this episode, Holly and Jim put their listeners to the test literally. They’ve built a 20-question pop quiz covering everything from the hidden biology of metabolic adaptation to the real findings from the National Weight Control Registry, the groundbreaking study Jim co-founded three decades ago. And because so much has changed recently, they’re also tackling the question everyone’s asking: does any of this still apply in the age of GLP-1 medications?

Grab a pen (or play along in your head) and see how many you get right. Some answers might surprise you, and a few might change how you think about your own weight loss journey for good.

Discussed on the episode:

• Why the biology of losing weight and the biology of keeping it off are two entirely different processes, and why not knowing this is setting you up to regain
• What really happens to your metabolism after weight loss, and whether “metabolic adaptation” is something you should actually be worried about
• The hunger hormone changes that don’t go away and what that means for your day-to-day life
• The real math behind the “energy gap,” a concept Jim and Holly coined themselves
• What the National Weight Control Registry’s 30,000+ members actually do differently, including the surprisingly unglamorous form of exercise most of them rely on
• Whether successful maintainers take weekends and holidays “off” from their habits
• The truth behind the infamous “95% of diets fail” statistic.
• Whether losing weight slowly really does make you more likely to keep it off.
• Why willpower isn’t the key predictor of long-term success and what is
• What happens to the body when someone stops taking a GLP-1 medication, and whether that counts as the medication “failing”
• The most vulnerable window for regain during medication-assisted weight loss and why most people prepare for the wrong phase
• A rapid-fire round covering daily weighing, running vs. walking, and the most overrated maintenance strategy out there

What did humans actually evolve to eat? With paleo, keto, vegan, Mediterranean, and a thousand other diets all claiming to be "the one," it's no wonder people feel whiplashed every time they walk into a grocery store. But what if the answer isn't found in the latest diet book, but in millions of years of human evolution?

Join Holly and Jim as they welcome back Harvard evolutionary biologist Dan Lieberman for a second appearance on the show. This time, Dan isn't talking exercise. He's talking food. Drawing on his new book, "Fed Up: What Evolution Reveals About Food, Diet, Health, and Eating Well," Dan explains why there's no single "evolutionary diet," why our supermarkets are a completely unprecedented environment for the human brain, and why willpower alone was never going to be enough. And because Dan doesn't just study diets, he lives them. He shares the surprisingly rough personal experiments he and his wife put themselves through in the name of research.

By the end of this episode, you'll understand exactly why eating well feels so hard in the modern world, and why that struggle has nothing to do with a lack of discipline.

Discussed on the episode:

• Why an evolutionary biologist says there's no such thing as "the" diet humans evolved to eat
• The "naturalistic fallacy" and why what our ancestors did isn't automatically what we should do
• What happened when Dan and his wife tried a raw food diet for several days (and why it ended with a bagel)
• The one natural food that's high in both sugar and fat, and what it reveals about why we crave certain foods
• How food processing quietly changed what's actually in your food, long before you ever open the package
• Why Dan calls modern ultra-processed foods "hyper-matched" to our brains
• The real reason low-carb and low-fat diets can both work, and why neither is right for everyone
• What Dan learned trying the Atkins diet as a self-described "carboholic"
• Why the Mediterranean diet keeps coming out on top, and whether that's fair to other traditional diets around the world
• His take on the vegan vs. carnivore debate, and why he wouldn't attempt one of them
• A listener's question about why the same diet can work great for one person and fail for their sibling
• Practical advice for eating well on a tight grocery budget
• The one thing Dan wants every listener to remember about their own struggles with food.

Resources mentioned:

• Dan Lieberman's book: "Fed Up: What Evolution Reveals About Food, Diet, Health, and Eating Well"

Most people trying to lose weight obsess over the what: what diet, what medication, what workout plan. But according to Holly and Jim, the real key to long-term success isn't found in any of those choices. It's found in a set of decisions most people never even realize they're making.

In this episode, Holly and Jim count down the 10 decisions that determine whether a weight loss journey actually sticks. Some are questions you'd expect. Others might catch you completely off guard, including the one they say most listeners will never predict is number one.

Whether you're just starting, deep into a GLP-1 medication, working to maintain weight you've already lost, or wondering if you're on the right plan at all, this countdown is built for you. So before you make your next move, find out if you've quietly been making these decisions by default or on purpose.

Discussed on the episode:

• The very first decision Holly says most people skip entirely and why it might surprise you coming from two people who host a weight loss podcast.
• Why a number on the scale might not mean what you think it means, and what "success" should really be measured by
• A newer, often-overlooked decision that's only become critical in the age of powerful weight loss medications
• The mindset shift that separates people who keep weight off from those who regain it
• Why hitting a plateau might actually be a sign you're succeeding, not failing.
• The surprising, deeply personal decision Holly and Jim rank as number one one they say most listeners will guess wrong

For years, the ceiling on medical weight loss was 15%, maybe 20% if you were lucky. Now a new triple-target medication is posting average results that flirt with 30% body weight loss in clinical trials, numbers once reserved for the operating room. Holly and Jim sat down to unpack what's driving these results, and found themselves asking a question neither expected to ask in their careers: how much weight loss is actually too much?

Retatrutide, the drug at the center of this episode, adds a third receptor target to the GLP-1 and GIP combination already familiar to listeners. Holly and Jim break down what this third piece brings to the table, walk through the newest published and presented trial data, and get refreshingly honest about the parts of this "medical miracle" that keep them up at night.

More weight loss isn't automatically better weight loss. As these medications get more powerful, Holly and Jim argue the field needs to catch up fast on nutrition, dosing, and what "success" even means going forward. If you've been following the GLP-1 story, this episode is the plot twist you didn't see coming.

Discussed on the episode:

• What makes this new medication a "triple agonist," and why adding a hormone best known for raising blood sugar might actually help with weight loss.
• The eye-opening trial results that have researchers using words like "mind-blowing" and why the number didn't plateau the way older treatments do
• A surprising new clinical worry that Holly never thought she'd hear herself say out loud
• Why "maximum dose" might not be the right goal for most people, even though it produces the biggest numbers
• The uncomfortable side effect that showed up more with this medication than with anything else on the market
• Whether switching medications is a good idea if what you're currently using is already working.
• The philosophical question Holly and Jim now find themselves asking about appetite itself and why silencing it completely might not be a win.
• A hint at what's coming next in obesity treatment, involving a hormone that hasn't entered the conversation yet

Can simply paying attention to your first bite of food change how much you eat? It sounds too simple to matter, but Holly and Jim are digging into a topic that might seem completely outside their lane: mindfulness and meditation.

For years, mindfulness has been filed under "stress management," not "weight management." But a growing body of research is asking a bigger question: can training the mind actually change the way we eat, not by altering our biology, but by changing how we respond to it? Holly and Jim break down a recent meta-analysis of dozens of studies to find out what's real, what's hype, and where this surprisingly powerful tool might fit into your own weight loss journey, especially the part everyone struggles with most: keeping the weight off.

Tune in as Holly and Jim separate the science from the sales pitch, tackle listener questions, and even reveal a personal update that might surprise you.

Discussed on the episode

• Why "eating on autopilot" happens to all of us and the moment Holly realized she was already halfway through a road trip sandwich she didn't remember eating
• The surprising reason automatic eating exists in the first place (hint: it's not laziness)
• What a 46-study meta-analysis reveals about mindfulness and eating behavior and why the effect is small but might matter more than you'd think
• Why this tool may matter far more for keeping weight off than for losing it in the first place
• The key difference between mindfulness and meditation (and why they get confused)
• A concept called "decentering" that could change the way you handle cravings
• Whether mindful eating is secretly just another diet in disguise
• One simple, five-minute-a-day habit almost anyone can start today.
• A rapid-fire round covering hunger vs. habit, biology vs. behavior, and myths about needing to "sit quietly with your eyes closed"
• A personal confession from Jim about a new daily practice he's been keeping quiet about

A few clicks online. No exam, no phone call, no video visit. Minutes later, a GLP-1 prescription is headed to your door. It sounds like the future of healthcare: fast, easy, convenient. But is convenience the same thing as care?

A Yale research team wanted to find out, so they built a fake patient, sent her to 49 different online GLP-1 providers, and tracked exactly what happened. What they found may change the way you think about getting these medications online and raise questions you didn't know to ask.

Join Holly and Jim as they unpack this eye-opening "secret shopper" study and use it to explore a much bigger question: when does convenience actually improve obesity care, and when does it quietly replace it? Whether you're currently taking a GLP-1, considering one, or just curious about where obesity treatment is headed, this episode will change how you evaluate any provider online or in person.

Discussed on the episode:

• The surprising percentage of online providers that approved a prescription in some cases in under five minutes
• The critical questions almost none of the 49 companies bothered to ask before prescribing a powerful medication
• Why "getting the meds" and "getting obesity care" are two very different things
• The real risks of starting a GLP-1 without a proper medical evaluation
• What compounded GLP-1s are, and why the vast majority of online prescriptions turned out to be compounded rather than brand-name
• Why your primary care doctor absolutely needs to know you're taking one of these medications (even if your online provider never asks)
• The dose-escalation practice that has Holly worried and why more medication isn't always better
• Holly and Jim's personal, unscripted stories about when convenience backfired in their own lives
• A simple framework for evaluating whether an online (or in-person) provider is actually giving you the care you deserve

For years, patients kept telling Holly the same strange thing: it wasn't the number on the scale that changed their life, it was something quieter, something they'd never had words for. They just didn't think about food anymore.

Now that experience has a name, and for the first time, a way to measure it. Food noise has gone from an offhand comment on social media to one of the most talked-about concepts in obesity science, and Holly and Jim are back to unpack how far the research has come since they last covered it.

Join Holly and Jim as they revisit food noise with fresh eyes. You'll hear how a handful of scattered patient stories turned into a full-blown scientific movement, what the newest validated tools can actually tell us, and why this "invisible" part of obesity might reshape how we think about treatment for years to come. Along the way, Holly and Jim get personal, sharing their own honest (and sometimes surprising) answers to whether they experience food noise themselves.

Discussed on the episode:

• How an unexpected side effect of GLP-1 medications turned into a full-blown scientific mystery
• The difference between food noise, hunger, and cravings, and why it matters more than you'd think
• Two newly validated tools researchers are using to measure something patients have described for years.
• A surprising decades-old study that raises the question: is food noise really new?
• A science-backed framework for understanding where food noise comes from in the brain
• Whether food noise could predict who regains weight, and who doesn't
• The big philosophical question: could reducing food noise become a treatment goal, even for people who don't need to lose weight?
• Holly and Jim's own personal, no-holds-barred answers to "do you have food noise?"
• What might happen to food noise if you stop taking a GLP-1 medication, and whether that means treatment "failed"

GLP-1 medications are the single most requested topic on the show, no contest. But with so much noise on social media, in doctors' offices, and everywhere in between, sorting fact from fiction has never been trickier. Some of what's out there is spot-on. Some of it is dangerously wrong.

So this week, Holly and Jim are flipping the format. Instead of another lecture, they're putting GLP-1 knowledge to the test with a 20-question quiz covering everything from the basic biology of these medications to the questions doctors themselves don't always get right. Grab a pen, keep score, and see how you stack up.

By the end of this episode, you'll have a clearer, science-backed answer to the questions you've been too afraid to ask or too confused by conflicting headlines to trust.

Discussed on the episode:

• The surprising truth about what GLP-1 medications are actually doing to your body (hint: it's not what most people think)
• Whether feeling less hungry is really a sign the medication is "working"
• Why a stalled scale might be the most normal thing that could happen to you
• The dosing myth that even well-meaning doctors sometimes get wrong
• What "success" really looks like when two people lose very different amounts of weight
• The truth behind "Ozempic face" and hair loss and whether the meds are really to blame
• Why almost everyone on a GLP-1 could benefit from one specific type of healthcare provider
• What to actually do (and not do) if you're eating less than 800 calories a day and still feel fine
• The real answer to "can I ever come off the medication?"
• Why those "natural GLP-1" gummies and supplements deserve a healthy dose of skepticism

We've all felt it: you decide to eat healthier, open social media, and within minutes, you're drowning in contradictory advice. Eggs are back. Butter's healthy. Seed oils are toxic. Never eat after 7pm. Wait, only eat between noon and 6pm? By the end, you're left wondering if anyone can just tell you what to eat.

Join Holly and Jim as they sit down with award-winning food journalist and registered dietitian Carolyn O'Neil to unpack why nutrition advice feels so exhausting and contradictory. With decades spent translating nutrition science for CNN and beyond, Carolyn has made a career out of turning "pie in the sky" science into "pie on the plate" advice people can actually use. In this conversation, she shares how to separate real science from clickbait, why food doesn't have to be the enemy, and how her philosophy of "the more you know, the more you can eat" can transform your relationship with food.

Whether you're confused by conflicting headlines, navigating a GLP-1 journey, or just trying to enjoy a family celebration without guilt, this episode is packed with practical, joyful wisdom from one of the most trusted voices in nutrition communication.

Discussed in the episode

• Why the two biggest buckets of nutrition headlines are "this will kill you" and "this will cure you," and why it's often the same food
• A simple media literacy trick for telling real science from a misleading headline
• What really happened in a viral study on omega-3 supplements and brain health
• Why the "Mediterranean diet" is more romanticized than most people realize
• How to keep the joy of eating alive while on a GLP-1 medication
• The restaurant industry's surprising response to guests eating less
• A simple framework, "the three M's," for personalizing your approach to health
• Why "shop the perimeter of the store" might be terrible advice.
• Carolyn's rapid-fire answers on the most overhyped nutrition claims, misleading headlines, and her favorite food city in the world
• A practical tip for enjoying food-centered family traditions without overeating or guilt

Cancer is the disease most people fear. But heart disease is the one that actually kills the most Americans, and most people never connect it to their weight. For decades, obesity was treated as a bystander to heart disease, a risk factor at best. That thinking has changed dramatically, and the data behind that shift is stunning: we now have a medication proven to cut major cardiovascular events by 20% in people with obesity.

Join Holly and Jim as they sit down with an old friend and true legend in the field, Dr. Robert Eckel, Professor Emeritus at the University of Colorado Anschutz Medical Campus. Bob is the only person to have ever served as president of the American Heart Association, the American Diabetes Association, and the Obesity Society, a hat trick that connects heart, metabolism, and weight in a way no one else in medicine can claim. He's been in the room for four decades of major turning points in this field, from the earliest meetings on obesity science to the current GLP-1 era.

In this episode, Bob walks Holly and Jim through the science, the skepticism, and the surprises behind the biggest shift in obesity treatment of their careers and answers real listener questions about medications, guidelines, and what patients should actually be asking their doctors.

Discussed in the episode:

• The pivotal trial that's changing how cardiologists think about weight loss drugs and how its results stack up against statins
• Why the outcome researchers expected to explain the benefits of these medications may not be the real story at all
• The surprising history of how "obesity" and "heart disease" became connected in medical thinking, and who had to make the case
• What your body's "set point" really is, and whether staying on medication long-term can actually change it
• A candid take on whether the weight-loss drugs might be helping or quietly working against long-term behavior change
• Real listener questions answered, including when a cardiologist won't prescribe, what "not overweight enough" really means, and whether weight loss "worked" even after a heart attack.
• Bob's own vulnerable reflections on his career, a decision he'd make differently, and what still keeps him "rewired" in retirement

For decades, one number has ruled the world of fitness: 10,000 steps. It's on your watch, your phone, maybe even tattooed into your daily to-do list. But what if that number was never based on science at all?

Join Holly and Jim as they sit down with Dr. Amanda Paluch, Associate Professor of Kinesiology at the University of Massachusetts Amherst and leader of the Steps for Health Collaborative, an international research consortium pooling data from over 125,000 adults to answer one deceptively simple question: how many steps do you actually need? Amanda pulls back the curtain on where the 10,000-step goal really came from, what the data shows instead, and why the "right" number might depend on how old you are. Whether you're chasing a step count, recovering from mobility limitations, or navigating GLP-1 medications, this conversation will change the way you think about your daily walk.

Discussed in the episode:

• The surprising 1960s marketing origin of the 10,000-step goal (hint: it has nothing to do with health research)
• Why the "right" step goal may look different depending on your age
• The step range where most of the cardiovascular benefit shows up (it's lower than you'd think)
• Whether walking pace matters as much as total volume
• How do steps fit into the GLP-1 conversation?
• What the research says about step counting becoming an unhealthy obsession
• Practical advice for people with mobility limitations who feel like step goals are out of reach
• Rapid-fire answers on walking vs. running, treadmill vs. outdoor steps, and more
• A simple mindset shift for anyone having a "low step day"

For 40 years, every time nutrition has found a new villain, the food industry has handed us a new label to go with it: non-fat, no GMOs, gluten-free, no seed oils, and now, non-ultra-processed. We have more experts, more studies, and more food rules than ever before, so why does standing in the grocery aisle still feel like such a guessing game?

Join Holly and Jim as they sit down with Tamar Haspel, the James Beard Award-winning Washington Post columnist behind Unearthed and author of To Boldly Grow, to pull apart the ultra-processed food debate and ask whether today's labels are actually helping us eat better or just making us easier to market to. Tamar doesn't just write about food from behind a desk: she gardens, fishes, raises chickens, and runs an oyster farm on Cape Cod, and she brings three decades of reporting, real skepticism, and zero patience for diet cranks to the conversation.

You'll hear why the food world keeps repeating the same mistake, what a cage full of B.F. Skinner's pigeons can teach us about our relationship with food, and what's really driving overeating once you strip away the marketing.

Discussed on the episode:

• The decades-old pattern that explains why every new food "villain" feels eerily familiar
• The bizarre pigeon experiment that reveals why we're so convinced certain foods are "good" or "bad" for us
• Why a bowl of crushed cereal proved more about overeating than years of processed-food headlines
• The blunt case for why "everything in moderation" might be the most useless diet advice out there
• The one-sentence grocery store rule that could replace almost every food label you've ever side-eyed
• How GLP-1 medications could end up reshaping the entire food industry, not just individual waistlines
• The "healthy" nutrient claim, Tamar says, is wildly overrated and the snack everyone blames for something it's not even guilty of

Losing weight on a GLP-1 medication can feel like magic until the scale stops moving. For almost everyone on these drugs, there comes a moment when the rapid progress slows, then stalls completely. Is the medication failing? Has your metabolism adapted? Did you do something wrong? For most people, that moment feels like a problem. It isn't.

Join Holly and Jim as they unpack one of the most misunderstood parts of the GLP-1 journey: the shift from losing weight to keeping it off. You'll discover why a stalled scale is actually a sign the medication is doing exactly what it's supposed to do, and why "maintenance" is a completely different physiological state than "weight loss." One that comes with its own rules. Along the way, you'll pick up science-backed (and some still-unanswered) guidance on nutrition, muscle, bone health, and motivation for the long haul, plus a clear answer to a question Holly says she gets all the time: Are they against staying on these medications long-term?

Discussed on the episode:

• Why hitting a plateau on a GLP-1 is good news, not a sign the drug has stopped working.
• The blood pressure pill comparison that reframes what people call "drug resistance"
• Why nutrition may matter even more, not less, once weight loss stops
• Whether you actually need to exercise to keep weight off on a GLP-1 (the honest answer might surprise you)
• The bone health risk in younger women that's getting far less attention than muscle loss
• Why are dose-tapering and switching strategies being called the "Wild West" of GLP-1 care
• A New York Times claim about these medications "rewiring the brain" and what that could mean long after you stop.
• How to find motivation once the scale refuses to budge

Have a question or a success story? Send it in. Holly and Jim read every one, and they're especially looking for listener stories about navigating weight loss maintenance.

What if the biggest obstacle to your health isn't your willpower, it's your zip code? Most of us have been raised to believe that weight and health come down to personal choices: what you eat, how much you move, how disciplined you are. But what if the deck has been stacked against millions of Americans before they ever make a single decision?

This week, Holly and Jim sit down with Dr. Christina Economos, Dean of the Friedman School of Nutrition Sciences and Policy at Tufts University, to explore one of the most important and most overlooked dimensions of the obesity epidemic: the environments we live in. With decades of groundbreaking research behind her, including the landmark Shape Up Somerville study, Dr. Economos makes a compelling case that lasting health change can't happen one person at a time.

And with GLP-1 medications reshaping what's possible for individual weight loss, the conversation has never been more urgent. Does community still matter when we have powerful new treatments? Dr. Economos has a clear answer, and it just might change how you see your own role in the bigger picture.

Discussed on the episode:

• The landmark study that proved community-wide obesity prevention actually works in the real world, and the surprising ripple effect it had beyond the children involved.
• Why your zip code may predict your health outcomes nearly as powerfully as your genetics
• The hidden forces in your neighborhood that are quietly shaping what you eat and how much you move, often without you realizing it
• What a food environment assessment in the Mississippi Delta revealed perfectly captures the challenge millions of Americans face daily
• Why fixing schools alone won't fix childhood obesity, and what actually needs to happen instead
• The honest answer to how much of the obesity epidemic is biology versus environment (hint: it's not a clean split)
• The key ingredients, Dr. Economos says, every successful community health intervention must have, and the #1 mistake researchers keep making
• How GLP-1 medications and community health are more connected than you might think
• What "spark plugs" are, why every successful health movement has had them, and whether you could be one
• Real U.S. communities that are getting this right and what they're actually doing differently
• Practical steps anyone can take right now, even if your environment is working against you